Kerstin Westman
11 – 20 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Long term azathioprine maintenance therapy in ANCA-associated vasculitis : combined results of long-term follow-up data
- Contribution to journal › Article
-
Mark
The European Vasculitis Society 2016 Meeting Report
- Contribution to journal › Article
-
Mark
Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
- Contribution to journal › Article
-
Mark
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
- Contribution to journal › Article
-
Mark
Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides
- Contribution to journal › Article
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
- Contribution to journal › Article
- 2016
-
Mark
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
ANCA-associated glomerulonephritis : Risk factors for renal relapse
- Contribution to journal › Article
- 2015
-
Mark
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
- Contribution to journal › Article
